The diagnostics industry saves lives every day and makes a significant contribution to optimal therapeutic success. Diagnostics and pharmaceuticals are increasingly cooperating in the development of new active substances, stratification of patients, and the safety and efficacy of therapies. The market for biomarkers is growing significantly. The diagnostics companies that can best adapt to the changing conditions will be the winners of this change: away from classic pay-per-result/pay-per-test business models towards value-driven diagnostics. We support you in meeting these changes in the best possible way with the help of optimized processes and customer value orientation on the way to significantly increased productivity and profitability.

Profitable growth

Business model transformation from classic diagnostics to companion.

Right first time

Significant reduction in time to market for new products.

Less process complexity, lower costs

Central labs receive thousands of samples per hour which need to linked to the sending physician, the patient and the payer prior to processing. Physical and administrative processing is complicated despite the latest automation techniques.


This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.